Webinar: Avoid The Valley of Death – Increase Confidence in Translational Research Using Biosimulation – September 12th
Only a third of preclinical programs make it to Phase 1 trials. Honing translational research is key to reducing the substantial financial risk associated with drug development. A new tool to help narrow the focus of preclinical programs is physiologically-based pharmacokinetic modeling (PBPK) modeling and simulation. Correct implementation can help predict human doses, find prime targets, and identify interactions.
